Mechanism of Action of Prochlorperazine
Prochlorperazine reduces nausea and vomiting primarily by blocking dopamine D2 receptors in the chemoreceptor trigger zone (area postrema) of the brain. 1, 2
Primary Mechanism: Central Dopamine D2 Receptor Antagonism
Prochlorperazine is a phenothiazine antipsychotic that exerts its antiemetic effects through potent antagonism of postsynaptic dopamine D2 receptors in the area postrema, the brain's chemoreceptor trigger zone responsible for detecting emetogenic stimuli. 1, 2
The drug blocks dopamine-mediated signaling at D2 receptors, preventing the neurotransmitter from activating pathways that trigger nausea and vomiting. 3, 4
Like other phenothiazines (including chlorpromazine), prochlorperazine shares structural conformational similarities with dopamine itself, allowing it to competitively occupy D2 receptor sites. 5
Additional Pharmacologic Properties
Prochlorperazine possesses anticholinergic effects that contribute to its antiemetic activity, though these are secondary to its dopaminergic blockade. 2
The drug has α-adrenergic blocking properties, which can result in hypotension as a side effect but may contribute to its overall sedative profile. 6, 7
Prochlorperazine demonstrates antihistaminic activity (H1 receptor antagonism), adding mild sedative effects that may be beneficial in managing nausea-associated anxiety. 6
Clinical Implications of the Mechanism
The dopamine D2 receptor blockade that provides antiemetic benefit is the same mechanism responsible for extrapyramidal side effects (dystonia, akathisia, parkinsonism) and the risk of tardive dyskinesia with prolonged use. 8, 9
Prochlorperazine's central dopaminergic antagonism explains why it has not been formally studied in gastroparesis trials—unlike prokinetic agents, it does not enhance gastric motility or accelerate gastric emptying. 1
The drug's mechanism makes it effective for nausea/vomiting but inappropriate for chronic daily use due to cumulative risk of movement disorders with long-term dopamine receptor blockade. 8, 9
Comparison to Related Agents
Prochlorperazine shares the same fundamental D2 receptor antagonism as other phenothiazines (chlorpromazine, promethazine), though promethazine has relatively stronger antihistaminic properties and weaker dopaminergic effects. 6, 7
Unlike 5-HT3 antagonists (ondansetron, granisetron) that block serotonin receptors peripherally and centrally, or NK-1 antagonists (aprepitant) that block substance P, prochlorperazine's antiemetic action is exclusively dopamine-mediated. 1, 10